These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18433022)

  • 1. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
    Campos GM; Bambha K; Vittinghoff E; Rabl C; Posselt AM; Ciovica R; Tiwari U; Ferrel L; Pabst M; Bass NM; Merriman RB
    Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL; Lee S; Hofmann LJ
    Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
    Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients.
    Ulitsky A; Ananthakrishnan AN; Komorowski R; Wallace J; Surapaneni SN; Franco J; Saeian K; Gawrieh S
    Obes Surg; 2010 Jun; 20(6):685-91. PubMed ID: 20336392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
    Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
    Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
    Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
    J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
    Tai CM; Yu ML; Tu HP; Huang CK; Hwang JC; Chuang WL
    Surg Obes Relat Dis; 2017 Apr; 13(4):686-692. PubMed ID: 28089433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
    Chisholm J; Seki Y; Toouli J; Stahl J; Collins J; Kow L
    Surg Obes Relat Dis; 2012; 8(4):416-22. PubMed ID: 21865094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery.
    Liang RJ; Wang HH; Lee WJ; Liew PL; Lin JT; Wu MS
    Obes Surg; 2007 Jan; 17(1):45-56. PubMed ID: 17355768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery.
    Pimentel SK; Strobel R; Gonçalves CG; Sakamoto DG; Ivano FH; Coelho JC
    Arq Gastroenterol; 2010; 47(2):170-3. PubMed ID: 20721462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.